Blavatnik Biomedical Accelerator
Offers Harvard biomedical innovators pilot support for early proof-of-concept delivery.
The Blavatnik Biomedical Accelerator (BBA) is Harvard's principal internal proof-of-concept funding mechanism for early-stage biomedical research, administered by the Harvard Office of Technology Development (OTD). The BBA was endowed with seed funding from the Blavatnik Family Foundation and is now operated entirely by Harvard OTD. It funds translation of early-stage research across four defined …
Proof-of-concept development of early-stage Harvard biomedical research across cell and gene therapy, infectious and inflammatory diseases, platform technologies, medical devices, therapeutics, diagnostics, drug delivery, and enabling technologies for drug discovery.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see the timeline
Guides for this application
All guides →Grants for Biotech Startups: NIH, NSF, SBIR/STTR, and Non-Dilutive Funding
A practical guide to grants for biotech startups, including NIH SBIR/STTR, NSF, translational funding, evidence, regulatory readiness, and budgets.
Write proposalGrant Proposal Sections: What Reviewers Expect in Each Part
A section-by-section guide to grant proposal format, project summaries, work plans, budgets, teams, letters of support, outcomes, and reviewer expectations.
Write proposalGrant Proposal Example: Sample Applications and What to Learn From Them
Learn how to use grant proposal examples, sample applications, and public funded proposals without copying weak structure or missing funder-specific rules.
More from Harvard OTD
All grants from this funder →Lab1636 — Harvard–Deerfield R&D Alliance
🇺🇸Harvard OTD · United States
Supports collaboration between Harvard and Deerfield to advance novel therapeutic discoveries toward clinical validation for patient impact.
Harvard Grid Accelerator — Awards
🇺🇸Harvard OTD · United States
Offers Harvard engineering teams startup support to take inventions from laboratory development to commercialization outcomes.
Similar grants
Browse the directory →
NCATS Clinical Trial Readiness for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies generating natural history data, biomarkers, and outcome measures needed to design clinical trials for rare diseases.
NIAID Investigator-Initiated P01
🇺🇸NIAID · United States
Supports investigator-led infectious disease and immunology multi-project teams under NIAID.
NCATS Preclinical Proof of Concept Studies for Rare Diseases
🇺🇸NCATS · United States
Funds U.S. researchers and companies conducting preclinical efficacy studies to advance therapeutic candidates for rare diseases toward IND applications.
NIMHD SBIR Phase IIB Strategic Breakthrough Award
🇺🇸NIMHD · United States
Funds prior NIH SBIR and STTR Phase II small businesses bridging later-stage R&D to commercialization.
NIAMS SBIR — Small Business Innovation Research
🇺🇸NIAMS · United States
Supports small businesses and researchers advancing arthritis, skin, and musculoskeletal innovation through staged aid.
NIDCR Extramural Research Grants
🇺🇸NIDCR · United States
Funds investigator-initiated oral, dental, and craniofacial research across United States institutions.